Quest Diagnostics, Inc. DGX

NYS: DGX | ISIN: US74834L1008 21/10/2025

184,64 USD (-3,03%)

(-3,03%) 21/10/2025

Grafiek Quest Diagnostics, Inc.

Grafiek Quest Diagnostics, Inc.

1 dag1d -3,03%
1 week1w -1,45%
1 maand1m -0,03%
3 maanden3m 3,59%
6 maanden6m 6,83%
1 jaar1j 17,25%
5 jaar5j 46,15%

Quest Diagnostics, Inc. in het nieuws

Toon enkel gratis nieuws

25 september 2025 · Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 · Persbericht

23 september 2025 · Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration · Persbericht

22 september 2025 · Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer · Persbericht

16 september 2025 · Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference · Persbericht

4 september 2025 · Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering · Persbericht

2 september 2025 · Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index · Persbericht

26 augustus 2025 · Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan · Persbericht

25 augustus 2025 · FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics · Persbericht

16 augustus 2025 · Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference · Persbericht

14 augustus 2025 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

Profiel Quest Diagnostics, Inc.

Diensten aan de gezondheidssector

Gezondheidszorg

Tandheelkundige laboratoria

Website: www.questdiagnostics.com

Hoofdzetel: Secaucus, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe